The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
A Review of Applications of Metabolomics in Cancer
Open accessAbstract
Cancer is a devastating disease that alters the metabolism of a cell and the surrounding milieu. Metabolomics is a growing and powerful technology capable of detecting hundreds to thousands of metabolites in tissues and biofluids. The recent advances in metabolomics technologies have enabled a deeper investigation into the metabolism of cancer and a better understanding of how cancer cells use glycolysis, known as the “Warburg effect,” advantageously to produce the amino acids, nucleotides and lipids necessary for tumor proliferation and vascularization. Currently, metabolomics research is being used to discover diagnostic cancer biomarkers in the clinic, to better understand its complex heterogeneous nature, to discover pathways involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide clues to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W.-M., Fiehn, O., Goodacre, R., Griffin, J. L., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0082-2 · Cited by 5,368 · cited 1×
“The metabolomics standards initiative (MSI) published minimum reporting standards for metabolomics studies involving in vivo samples [34], chemical analysis [35], NMR-based metabolomics [36], and data analysis [37].”
BackgroundSelf-citationWhy Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Metabolomics—the link between genotypes and phenotypes
Fiehn, O. (2002) · Plant Molecular Biology · doi:10.1023/a:1013713905833 · Cited by 3,445
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294 · cited 3×
“During metabolomics data acquisition, quality control is needed to ensure that the data are captured in a reproducible manner and provide meaningful results [41,46,47].”
BackgroundHMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,231
Metabolomics — the link between genotypes and phenotypes
Fiehn, O. (2002) · Functional Genomics · doi:10.1007/978-94-010-0448-0_11 · Cited by 3,167
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
METLIN—a metabolite mass spectral database
Smith, C. A., Maille, G. O., Want, E. J., Qin, C., Trauger, S. A., Brandon, T. R., Custodio, D. E., Abagyan, R., & Siuzdak, G. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000179845.53213.39 · Cited by 2,226
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Metabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
HMDB: a knowledgebase for the human metabolome
Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., Hau, D. D., Psychogios, N., Dong, E., Bouatra, S., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn810 · Cited by 1,873
Psychogios, N., Hau, D. D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., Sinelnikov, I., Krishnamurthy, R., Eisner, R., Gautam, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016957 · Cited by 1,703
(1989) · PubMed · Cited by 1,639
Metabolomics--the link between genotypes and phenotypes.
Fiehn, O. (2002) · PubMed · Cited by 1,517
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
GMD@CSB.DB: the Golm Metabolome Database
Kopka, J., Schauer, N., Krueger, S., Birkemeyer, C., Usadel, B., Bergmuller, E., Dormann, P., Weckwerth, W., Gibon, Y., Stitt, M., et al. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti236 · Cited by 1,382
LMSD: LIPID MAPS structure database
Sud, M., Fahy, E., Cotter, D., Brown, A., Dennis, E. A., Glass, C. K., Merrill, A. H., Murphy, R. C., Raetz, C. R. H., Russell, D. W., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl838 · Cited by 1,375
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3483 · Cited by 1,324
Cancer's Molecular Sweet Tooth and the Warburg Effect
Kim, J.-W., & Dang, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1501 · Cited by 1,215
Metabolomics: Current analytical platforms and methodologies
(2005) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2004.11.021 · Cited by 1,192
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Roessner, U., Luedemann, A., Brust, D., Fiehn, O., Linke, T., Willmitzer, L., & Fernie, A. R. (2001) · The Plant Cell · doi:10.1105/tpc.13.1.11 · Cited by 1,017
Gut microorganisms, mammalian metabolism and personalized health care
Nicholson, J. K., Holmes, E., & Wilson, I. D. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1152 · Cited by 945
Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks
Fiehn, O. (2001) · Comparative and Functional Genomics · doi:10.1002/cfg.82 · Cited by 934
Han, X., & Gross, R. W. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300004-jlr200 · Cited by 914 · cited 1×
“Lipidomics is a specialized subset of metabolomics that evaluates lipid profiles [22,23].”
BackgroundPharmaco-metabonomic phenotyping and personalized drug treatment
Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824 · cited 1×
“Therefore, metabolomics alterations represent changes in the phenotype and molecular physiology [1–3].”
BackgroundMetabolic Phenotyping in Health and Disease
Holmes, E., Wilson, I. D., & Nicholson, J. K. (2008) · Cell · doi:10.1016/j.cell.2008.08.026 · Cited by 822
Statistical strategies for avoiding false discoveries in metabolomics and related experiments
Broadhurst, D. I., & Kell, D. B. (2007) · Metabolomics · doi:10.1007/s11306-006-0037-z · Cited by 817
Clinical Applications of Metabolomics in Oncology: A Review
Spratlin, J. L., Serkova, N. J., & Eckhardt, S. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1059 · Cited by 753
Metabolic profiles of cancer cells
Griffin, J. L., & Shockcor, J. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1390 · Cited by 725
Metabolomics: A Global Biochemical Approach to Drug Response and Disease
Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 670
Seyfried, T. N., & Shelton, L. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-7 · Cited by 644
Data processing for mass spectrometry-based metabolomics
Katajamaa, M., & Orešič, M. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.04.021 · Cited by 616 · cited 1×
“First, the data is processed using vendor software or specialized bioinformatics software for analyzing metabolomics data [51–53].”
MethodLipidomics: New Tools and Applications
Wenk, M. R. (2010) · Cell · doi:10.1016/j.cell.2010.11.033 · Cited by 589
Sangster, T., Major, H., Plumb, R., Wilson, A. J., & Wilson, I. D. (2006) · The Analyst · doi:10.1039/b604498k · Cited by 564
Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
Warner, E., Messersmith, H., Causer, P., Eisen, A., Shumak, R., & Plewes, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00007 · Cited by 564
Chemometrics in metabolomics—A review in human disease diagnosis
Madsen, R., Lundstedt, T., & Trygg, J. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2009.11.042 · Cited by 557
Metabolic phenotyping in clinical and surgical environments
Nicholson, J. K., Holmes, E., Kinross, J. M., Darzi, A. W., Takats, Z., & Lindon, J. C. (2012) · Nature · doi:10.1038/nature11708 · Cited by 546
Metabonomics in Toxicology: A Review
Robertson, D. G. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi102 · Cited by 541
Hilvo, M., Denkert, C., Lehtinen, L., Müller, B., Brockmöller, S., Seppänen-Laakso, T., Budczies, J., Bucher, E., Yetukuri, L., Castillo, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3894 · Cited by 532
Analytical Strategies in Metabonomics
Lenz, E. M., & Wilson, I. D. (2007) · Journal of Proteome Research · doi:10.1021/pr0605217 · Cited by 530
New approaches for imaging tumour responses to treatment
Brindle, K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2289 · Cited by 460
Chan, E. C. Y., Koh, P. K., Mal, M., Cheah, P. Y., Eu, K. W., Backshall, A., Cavill, R., Nicholson, J. K., & Keun, H. C. (2009) · Journal of Proteome Research · doi:10.1021/pr8006232 · Cited by 444
Proposed minimum reporting standards for data analysis in metabolomics
Goodacre, R., Broadhurst, D., Smilde, A. K., Kristal, B. S., Baker, J. D., Beger, R., Bessant, C., Connor, S., Capuani, G., Craig, A., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0081-3 · Cited by 442
Self-citationDunn, W. B., Wilson, I. D., Nicholls, A. W., & Broadhurst, D. (2012) · Bioanalysis · doi:10.4155/bio.12.204 · Cited by 442
ANTAGONISTS OF NUCLEIC ACID DERIVATIVES
Elion, G. B., Singer, S., & Hitchings, G. H. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65573-5 · Cited by 427
Poli, D., Carbognani, P., Corradi, M., Goldoni, M., Acampa, O., Balbi, B., Bianchi, L., Rusca, M., & Mutti, A. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-71 · Cited by 415
Moreadith, R. W., & Lehninger, A. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82128-0 · Cited by 414
Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer
Glunde, K., Jie, C., & Bhujwalla, Z. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3829 · Cited by 380
Dowling, C., Bollen, A. W., Noworolski, S. M., McDermott, M. W., Barbaro, N. M., Day, M. R., Henry, R. G., Chang, S. M., Dillon, W. P., Nelson, S. J., et al. (2001) · PubMed Central · Cited by 378
The role of metabolites and metabolomics in clinically applicable biomarkers of disease
Mamas, M., Dunn, W. B., Neyses, L., & Goodacre, R. (2011) · Archives of Toxicology · doi:10.1007/s00204-010-0609-6 · Cited by 376
Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
Singh, A., Happel, C., Manna, S. K., Acquaah-Mensah, G., Carrerero, J., Kumar, S., Nasipuri, P., Krausz, K. W., Wakabayashi, N., Dewi, R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66353 · Cited by 333
High‐resolution magic angle spinning MRS of breast cancer tissue
Sitter, B., Sonnewald, U., Spraul, M., Fjösne, H. E., & Gribbestad, I. S. (2002) · NMR in Biomedicine · doi:10.1002/nbm.775 · Cited by 323
Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics
Odunsi, K., Wollman, R. M., Ambrosone, C. B., Hutson, A., McCann, S. E., Tammela, J., Geisler, J. P., Miller, G., Sellers, T., Cliby, W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20651 · Cited by 317
Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe, J., Jung, J. U., Gandour-Edwards, R., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 317
bioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis
Sugimoto, M., Kawakami, M., Robert, M., Soga, T., & Tomita, M. (2012) · Current Bioinformatics · doi:10.2174/157489312799304431 · Cited by 307
Glycolysis, glutaminolysis and cell proliferation
MCKEEHAN, W. (1982) · Cell Biology International Reports · doi:10.1016/0309-1651(82)90125-4 · Cited by 305
Overexpression and overactivation of Akt in thyroid carcinoma.
Ringel, M. D., Hayre, N., Saito, J., Saunier, B., Schuppert, F., Burch, H., Bernet, V., Burman, K. D., Kohn, L. D., & Saji, M. (2001) · PubMed · Cited by 297
Ackerstaff, E., Pflug, B. R., Nelson, J. B., & Bhujwalla, Z. M. (2001) · PubMed · Cited by 285
Patterson, A. D., Maurhofer, O., Beyoğlu, D., Lanz, C., Krausz, K. W., Pabst, T., Gonzalez, F. J., Dufour, J.-F., & Idle, J. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0885 · Cited by 268
Metabolomics in the study of kidney diseases
Weiss, R. H., & Kim, K. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.152 · Cited by 264
Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells?
Dang, C. V. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13302 · Cited by 245
Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics
Saddoughi, S. A., Song, P., & Ogretmen, B. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_16 · Cited by 243
ANTAGONISTS OF NUCLEIC ACID DERIVATIVES
Hitchings, G. H., Falco, E. A., Vanderwerff, H., Russell, P. B., & Elion, G. B. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)44808-9 · Cited by 235
Prediction of breast cancer using volatile biomarkers in the breath
Phillips, M., Cataneo, R. N., Ditkoff, B. A., Fisher, P., Greenberg, J., Gunawardena, R., Kwon, C. S., Tietje, O., & Wong, C. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9176-1 · Cited by 235
Identification of Biological Tissues by Rapid Evaporative Ionization Mass Spectrometry
Balog, J., Szaniszlo, T., Schaefer, K.-C., Denes, J., Lopata, A., Godorhazy, L., Szalay, D., Balogh, L., Sasi-Szabo, L., Toth, M., et al. (2010) · Analytical Chemistry · doi:10.1021/ac101283x · Cited by 231
Sphingosine Kinase Type 1 Promotes Estrogen-Dependent Tumorigenesis of Breast Cancer MCF-7 Cells
Nava, V (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5658 · Cited by 226
YANG, J., XU, G., ZHENG, Y., KONG, H., PANG, T., LV, S., & YANG, Q. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.09.032 · Cited by 210
Sarkar, S., Maceyka, M., Hait, N. C., Paugh, S. W., Sankala, H., Milstien, S., & Spiegel, S. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.055 · Cited by 205
Pöttgen, C., Levegrün, S., Theegarten, D., Marnitz, S., Grehl, S., Pink, R., Eberhardt, W., Stamatis, G., Gauler, T., Antoch, G., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0510 · Cited by 204
Tessem, M., Swanson, M. G., Keshari, K. R., Albers, M. J., Joun, D., Tabatabai, Z. L., Simko, J. P., Shinohara, K., Nelson, S. J., Vigneron, D. B., et al. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21694 · Cited by 200
Urine stability for metabolomic studies: effects of preparation and storage
Saude, E. J., & Sykes, B. D. (2007) · Metabolomics · doi:10.1007/s11306-006-0042-2 · Cited by 198
PGC1α Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis
Bhalla, K., Hwang, B. J., Dewi, R. E., Ou, L., Twaddel, W., Fang, H.-B., Vafai, S. B., Vazquez, F., Puigserver, P., Boros, L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1011 · Cited by 190
Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers
Woo, H. M., Kim, K. M., Choi, M. H., Jung, B. H., Lee, J., Kong, G., Nam, S. J., Kim, S., Bai, S. W., & Chung, B. C. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.10.014 · Cited by 182
Fonville, J. M., Richards, S. E., Barton, R. H., Boulangé, C. L., Ebbels, T. M. D., Nicholson, J. K., Holmes, E. C., & Dumas, M. (2010) · Journal of Chemometrics · doi:10.1002/cem.1359 · Cited by 180
Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Friess, H., Langhans, J., Ebert, M., Beger, H. G., Stollfuss, J., Reske, S. N., & Büchler, M. W. (1995) · Gut · doi:10.1136/gut.36.5.771 · Cited by 178
A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer
Kobayashi, T., Nishiumi, S., Ikeda, A., Yoshie, T., Sakai, A., Matsubara, A., Izumi, Y., Tsumura, H., Tsuda, M., Nishisaki, H., et al. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1033 · Cited by 177
Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer
Ikeda, A., Nishiumi, S., Shinohara, M., Yoshie, T., Hatano, N., Okuno, T., Bamba, T., Fukusaki, E., Takenawa, T., Azuma, T., et al. (2012) · Biomedical Chromatography · doi:10.1002/bmc.1671 · Cited by 176
Metabolic Characterization of Human Prostate Cancer with Tissue Magnetic Resonance Spectroscopy
Cheng, L. L., Burns, M. A., Taylor, J. L., He, W., Halpern, E. F., McDougal, W. S., & Wu, C.-L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4106 · Cited by 171
Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification
Nam, H., Chung, B. C., Kim, Y.-H., Lee, K., & Lee, D. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp558 · Cited by 158
Metabolite quantification and high‐field MRS in breast cancer
Haddadin, I., McIntosh, A., Meisamy, S., Corum, C. A., Snyder, A., Powell, N. J., Nelson, M. T., Yee, D., Garwood, M., & Bolan, P. J. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1217 · Cited by 155
Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect
Weljie, A. M., & Jirik, F. R. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.009 · Cited by 155
Rantalainen, M., Cloarec, O., Beckonert, O. P., Wilson, I. D., Jackson, D. P., Tonge, R., Rowlinson, R. A., Rayner, S., Nickson, J. A., Wilkinson, R. W., et al. (2006) · Journal of Proteome Research · doi:10.1021/pr060124w · Cited by 153
Urine metabolomics for kidney cancer detection and biomarker discovery
Ganti, S. N., & Weiss, R. H. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.05.013 · Cited by 148
Alterations of metabolic genes and metabolites in cancer
Oermann, E. K., Wu, J., Guan, K., & Xiong, Y. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.013 · Cited by 139
Bioinformatics tools for cancer metabolomics
Blekherman, G., Laubenbacher, R., Cortes, D. F., Mendes, P., Torti, F. M., Akman, S. A., Torti, S. V., & Shulaev, V. (2011) · Metabolomics · doi:10.1007/s11306-010-0270-3 · Cited by 136
The metabolic advantage of tumor cells
Israël, M., & Schwartz, L. H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-70 · Cited by 134
Serum metabolomics as a novel diagnostic approach for pancreatic cancer
Nishiumi, S., Shinohara, M., Ikeda, A., Yoshie, T., Hatano, N., Kakuyama, S., Mizuno, S., Sanuki, T., Kutsumi, H., Fukusaki, E., et al. (2010) · Metabolomics · doi:10.1007/s11306-010-0224-9 · Cited by 126
Magic Angle Spinning NMR-Based Metabolic Profiling of Head and Neck Squamous Cell Carcinoma Tissues
Somashekar, B. S., Kamarajan, P., Danciu, T., Kapila, Y. L., Chinnaiyan, A. M., Rajendiran, T. M., & Ramamoorthy, A. (2011) · Journal of Proteome Research · doi:10.1021/pr200800w · Cited by 119
Functional Magnetic Resonance Imaging in Prostate Cancer
Seitz, M., Shukla‐Dave, A., Bjartell, A. S., Touijer, K. A., Sciarra, A., Bastian, P. J., Stief, C. G., Hricak, H., & Graser, A. (2009) · European Urology · doi:10.1016/j.eururo.2009.01.027 · Cited by 119
Lipid-based biomarkers for cancer
Fernandis, A. Z., & Wenk, M. R. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.06.015 · Cited by 118
Backshall, A., Sharma, R., Clarke, S. J., & Keun, H. C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2474 · Cited by 118
Radiation metabolomics and its potential in biodosimetry
Coy, S. L., Cheema, A. K., Tyburski, J. B., Laiakis, E. C., Collins, S. P., & Fornace, A. J. (2011) · International Journal of Radiation Biology · doi:10.3109/09553002.2011.556177 · Cited by 102
Serkova, N. J., & Glunde, K. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-811-9_20 · Cited by 99
Vizán, P., Sánchez‐Tena, S., Alcarraz‐Vizán, G., Soler, M., Messeguer, R., Pujol, M. D., Lee, W.-N. P., & Cascante, M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp083 · Cited by 99
Ma, Y., Zhang, P., Wang, F., Liu, W., Yang, J., & Qin, H. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31824a9a8b · Cited by 98
Lv, W., & Yang, T. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.10.011 · Cited by 96
Yan, S.-K., Wei, B.-J., Lin, Z.-Y., Yang, Y., Zhou, Z.-T., & Zhang, W.-D. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2007.06.007 · Cited by 95
Johnson, C. H., Patterson, A. D., Krausz, K. W., Lanz, C., Kang, D. W., Luecke, H. F., Gonzalez, F. J., & Idle, J. R. (2011) · Radiation Research · doi:10.1667/rr2437.1 · Cited by 95
Metabolomics In Biomarker Discovery: Future Uses For Cancer Prevention
Kim, Y. S., Maruvada, P., & Milner, J. A. (2008) · Future Oncology · doi:10.2217/14796694.4.1.93 · Cited by 94
Ben‐Yoseph, O., Badar‐Goffer, R. S., Morris, P. G., & Bachelard, H. S. (1993) · Biochemical Journal · doi:10.1042/bj2910915 · Cited by 90
Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma
Beger, R. D., Schnackenberg, L. K., Holland, R. D., Li, D., & Dragan, Y. P. (2006) · Metabolomics · doi:10.1007/s11306-006-0026-2 · Cited by 88
Self-citationLane, A. N., Fan, T. W. ‐., Bousamra, M., Higashi, R. M., Yan, J., & Miller, D. M. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0088 · Cited by 87
Metabolomics, Pathway Regulation, and Pathway Discovery
Zhang, G., Sadhukhan, S., Tochtrop, G. P., & Brunengraber, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.171405 · Cited by 86
Brown, M. V., McDunn, J. E., Gunst, P. R., Smith, E. M., Milburn, M. V., Troyer, D. A., & Lawton, K. A. (2012) · Genome Medicine · doi:10.1186/gm332 · Cited by 84
Guidance for Industry: Pharmacogenomic Data Submissions
(2004) · Biotechnology Law Report · doi:10.1089/073003104322838303 · Cited by 83
Osl, M., Dreiseitl, S., Pfeifer, B. E., Weinberger, K. M., Klocker, H., Bartsch, G. H., Schäfer, G., TILG, B., Graber, A., & Baumgärtner, C. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn506 · Cited by 80
Bertilsson, H., Tessem, M., Flatberg, A., Viset, T., Gribbestad, I. S., Angelsen, A., & Halgunset, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2929 · Cited by 80
Griffin, J. L., Nicholls, A. W., Daykin, C. A., Heald, S. L., Keun, H. C., Schuppe‐Koistinen, I., Griffiths, J. R., Cheng, L. L., Rocca‐Serra, P., Rubtsov, D. V., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0077-z · Cited by 76
1H NMR Metabolomics Analysis of Glioblastoma Subtypes
Čuperlović‐Culf, M., Ferguson, D., Culf, A. S., Morin, P., & Touaibia, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337196 · Cited by 75
A generic operational strategy to qualify translational safety biomarkers
Matheis, K. A., Laurie, D., Andriamandroso, C., Arber, N., Badimón, L., Benain, X., Bendjama, K., Clavier, I., Colman, P., Firat, H., et al. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.04.011 · Cited by 73
Determination of serum lysophosphatidic acid as a potential biomarker for ovarian cancer
Meleh, M., Požlep, B., Mlakar, A., et al. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.08.008 · Cited by 69
Yokota, H., Guo, J., Matoba, M., Higashi, K., Tonami, H., & Nagao, Y. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20902 · Cited by 68
Griffiths, J. R., & Stubbs, M. (2003) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(02)00030-4 · Cited by 62
COMPARATIVE METABOLOMICS OF BREAST CANCER
Chen, Y., Richardson, A. D., Smith, J. W., et al. (2006) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789812772435_0018 · Cited by 62
Translational Medicine and the Value of Biomarker Qualification
Goodsaid, F. M., & Mendrick, D. L. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001040 · Cited by 62
Magnetic resonance imaging and spectroscopy of prostate cancer.
Carroll, P. R., Coakley, F. V., & Kurhanewicz, J. V. (2006) · Europe PMC (PubMed Central) · Cited by 59
Sardanelli, F., Fausto, A., & Podo, F. (2008) · La radiologia medica · doi:10.1007/s11547-008-0228-y · Cited by 58
Türkbey, B., Aras, Ö., Karabulut, N., Turgut, A. T., Akpınar, E., Alibek, S., Pang, Y., Ertürk, Ş. M., Khouli, R. H. E., Bluemke, D. A., et al. (2011) · Diagnostic and Interventional Radiology · doi:10.4261/1305-3825.dir.4708-11.2 · Cited by 57
Proposed reporting requirements for the description of NMR-based metabolomics experiments
Rubtsov, D. V., JENKINS, H. A., Ludwig, C., Easton, J. M., Viant, M. R., Günther, U. L., Griffin, J. L., & Hardy, N. W. (2007) · Metabolomics · doi:10.1007/s11306-006-0040-4 · Cited by 57
Boros, L., Brackett, D. J., & Harrigan, G. G. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481769 · Cited by 57
Eckhart, A. D., Beebe, K. D., & Milburn, M. (2012) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00388.x · Cited by 53
Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis
Yauch, R. L., & Settleman, J. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.01.003 · Cited by 50
Boros, L., Lerner, M. R., Morgan, D. L., Taylor, S. L., Smith, B. J., Postier, R. G., & Brackett, D. J. (2005) · Pancreas · doi:10.1097/01.mpa.0000186524.53253.fb · Cited by 48
Metabolomic analysis of cancer cachexia reveals distinct lipid and glucose alterations
O’Connell, T. M., Ardeshirpour, F., Asher, S. A., Winnike, J. H., Yin, X., George, J. R., D, D. C. G., He, W., Wysong, A. S., Willis, M. S., et al. (2008) · Metabolomics · doi:10.1007/s11306-008-0113-7 · Cited by 47
Advanced imaging techniques in brain tumors
Law, M. (2009) · Cancer Imaging · doi:10.1102/1470-7330.2009.9002 · Cited by 47
Prospects for clinical cancer metabolomics using stable isotope tracers
Lane, A. N., Fan, T. W. ‐., Higashi, R. M., Tan, J., Bousamra, M., & Miller, D. M. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.005 · Cited by 46
Bayet‐Robert, M., Morvan, D., Chollet, P. J. M., & Barthomeuf, C. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0430-1 · Cited by 45
Beger, R. D., Hansen, D. K., Schnackenberg, L. K., Cross, B. M., Fatollahi, J. J., Lagunero, F. T., Sarnyai, Z., & Boros, L. G. (2009) · Metabolomics · doi:10.1007/s11306-009-0159-1 · Cited by 35
Self-citationUsing Metabolomics to Monitor Anticancer Drugs
Chung, Y., & Griffiths, J. R. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_089 · Cited by 32
Metabolomics data and the biomarker qualification process
Beger, R. D., & Colatsky, T. J. (2011) · Metabolomics · doi:10.1007/s11306-011-0342-z · Cited by 25
Self-citationBoros, L. G. (2005) · Metabolomics · doi:10.1007/s11306-005-1103-7 · Cited by 24
Surgical Systems Biology and Personalized Longitudinal Phenotyping in Critical Care
Muirhead, L. J., Kinross, J. K., FitzMaurice, T. S., Takáts, Z., Darzi, A. W., & Nicholson, J. K. (2012) · Personalized Medicine · doi:10.2217/pme.12.70 · Cited by 7
Cited by
Saliva diagnostics – Current views and directions
Kaczor-Urbanowicz, K. E., Martin Carreras-Presas, C., Aro, K., Tu, M., Garcia-Godoy, F., & Wong, D. T. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370216681550 · Cited by 472
Mechanoresponsive metabolism in cancer cell migration and metastasis
Zanotelli, M. R., Zhang, J., & Reinhart-King, C. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.002 · Cited by 338
Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment
Pinker, K., Chin, J., Melsaether, A. N., Morris, E. A., & Moy, L. (2018) · Radiology · doi:10.1148/radiol.2018172171 · Cited by 275
Recent advances in microfluidic methods in cancer liquid biopsy
Iliescu, F. S., Poenar, D. P., Yu, F., Ni, M., Chan, K. H., Cima, I., Taylor, H. K., Cima, I., & Iliescu, C. (2019) · Biomicrofluidics · doi:10.1063/1.5087690 · Cited by 51
The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
Moreno-Torres, M., Quintás, G., & Castell, J. V. (2022) · Metabolites · doi:10.3390/metabo12060564 · Cited by 50
Metadata
- Authors
- Beger, R.
- Venue
- Metabolites
- Publisher
- MDPI AG
- Published
- 2013-07-05
- Volume
- 3
- Issue
- 3
- Pages
- 552-574
- ISSN
- 2218-1989 (ISSN-L)
- OpenAlex
- W2065342065
- Cited by
- 288
- References
- 137
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.